Opioid Receptor Gene (OPRM1, OPRK1, and OPRD1) Variants and Response to Naltrexone Treatment for Alcohol Dependence: Results From the VA Cooperative Study
Article first published online: 12 FEB 2007
Alcoholism: Clinical and Experimental Research
Volume 31, Issue 4, pages 555–563, April 2007
How to Cite
Gelernter, J., Gueorguieva, R., Kranzler, H. R., Zhang, H., Cramer, J., Rosenheck, R., Krystal, J. H. and the VA Cooperative Study #425 Study Group (2007), Opioid Receptor Gene (OPRM1, OPRK1, and OPRD1) Variants and Response to Naltrexone Treatment for Alcohol Dependence: Results From the VA Cooperative Study. Alcoholism: Clinical and Experimental Research, 31: 555–563. doi: 10.1111/j.1530-0277.2007.00339.x
This work was supported in part by funds from the U.S. Department of Veterans Affairs [VA Alcohol Research Center, the VA Medical Research Program and the VA Connecticut-Massachusetts Mental Illness Research, Education and Clinical Center (MIRECC), and the VA Research Enhancement Award Program (REAP)], the National Institute on Drug Abuse (Grants R01-DA12849, R01-DA12690, and K24-DA15105), and the National Institute on Alcohol Abuse and Alcoholism (Grants R01-AA11330, K08-AA13732, K05 AA 14906-01, P50 AA-12870-04, and K24-AA13736).
- Issue published online: 12 FEB 2007
- Article first published online: 12 FEB 2007
- Received for publication August 28, 2006; accepted January 2, 2007.